{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T20:05:08Z","timestamp":1791317108587,"version":"4.3.1"},"reference-count":36,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,13]],"date-time":"2022-07-13T00:00:00Z","timestamp":1657670400000},"content-version":"vor","delay-in-days":377,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100005035","name":"Biotronik","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005035","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000895","name":"St. Jude Medical Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000895","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001316","name":"Abbott Laboratories","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001316","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008897","name":"Janssen Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006279","name":"St. Jude Medical","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006279","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008497","name":"Boston Scientific Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008497","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007497","name":"Biosense Webster","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007497","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000871","name":"Mayo Clinic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006093","name":"Patient-Centered Outcomes Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006093","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004374","name":"Medtronic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004374","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U01HL089786"],"award-info":[{"award-number":["U01HL089786"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U01HL089907"],"award-info":[{"award-number":["U01HL089907"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U01HL089645"],"award-info":[{"award-number":["U01HL089645"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U01HL89709"],"award-info":[{"award-number":["U01HL89709"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001003","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001003","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002491","name":"Bristol-Myers Squibb","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002491","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American College of Cardiology"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.jacc.2021.04.092","type":"journal-article","created":{"date-parts":[[2021,7,5]],"date-time":"2021-07-05T17:38:53Z","timestamp":1625506733000},"page":"126-138","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"title":["Ablation Versus Drug Therapy for Atrial Fibrillation in Racial and Ethnic Minorities"],"prefix":"10.1016","volume":"78","author":[{"given":"Kevin L.","family":"Thomas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hussein R.","family":"Al-Khalidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam P.","family":"Silverstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristi H.","family":"Monahan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tristram D.","family":"Bahnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeanne E.","family":"Poole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel B.","family":"Mark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas L.","family":"Packer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacc.2021.04.092_bib1","doi-asserted-by":"crossref","first-page":"e445","DOI":"10.1016\/j.hrthm.2017.07.009","article-title":"2017 HRS\/EHRA\/ECAS\/APHRS\/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation: executive summary","volume":"14","author":"Calkins","year":"2017","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacc.2021.04.092_bib2","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.jacep.2020.03.001","article-title":"Under-reporting and under-representation of racial\/ethnic minorities in major atrial fibrillation clinical\u00a0trials","volume":"6","author":"Sarraju","year":"2020","journal-title":"JACC Clin Electrophysiol"},{"key":"10.1016\/j.jacc.2021.04.092_bib3","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1111\/jce.13439","article-title":"Geographic and racial representation and reported success rates of studies of catheter ablation for atrial fibrillation: findings from the SMASH-AF meta-analysis study cohort","volume":"29","author":"Leef","year":"2018","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.jacc.2021.04.092_bib4","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1111\/j.1540-8167.2011.02043.x","article-title":"Demographic profile of patients undergoing catheter ablation of atrial fibrillation","volume":"22","author":"Hoyt","year":"2011","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.jacc.2021.04.092_bib5","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1016\/j.hrthm.2015.03.031","article-title":"Race- and sex-related differences in care for patients newly diagnosed with atrial fibrillation","volume":"12","author":"Bhave","year":"2015","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacc.2021.04.092_bib6","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1016\/j.amjcard.2016.02.016","article-title":"Racial differences in the prevalence and outcomes of atrial fibrillation in patients hospitalized with heart failure","volume":"117","author":"Bhatia","year":"2016","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2021.04.092_bib7","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/s10903-016-0545-5","article-title":"Impact of race on outcome of patients undergoing rhythm control of atrial fibrillation","author":"Durrani","year":"2018","journal-title":"J\u00a0Immigr Minor Health"},{"key":"10.1016\/j.jacc.2021.04.092_bib8","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ahj.2015.10.028","article-title":"Racial\/ethnic differences in atrial fibrillation symptoms, treatment patterns, and outcomes: insights from Outcomes Registry for Better Informed Treatment for Atrial Fibrillation Registry","volume":"174","author":"Golwala","year":"2016","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2021.04.092_bib9","first-page":"144","article-title":"Racial disparities in hospitalizations, procedural treatments and mortality of patients hospitalized with atrial fibrillation","volume":"24","author":"Naderi","year":"2014","journal-title":"Ethn Dis"},{"key":"10.1016\/j.jacc.2021.04.092_bib10","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1002\/clc.22330","article-title":"Racial disparities in the use of catheter ablation for atrial fibrillation and flutter","volume":"37","author":"Tamariz","year":"2014","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.jacc.2021.04.092_bib11","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1001\/jama.2019.0693","article-title":"Effect of catheter ablation vs antiarrhythmic drug therapy on mortality, stroke, bleeding, and cardiac arrest among patients with atrial fibrillation: the CABANA randomized clinical trial","volume":"321","author":"Packer","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2021.04.092_bib12","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1001\/jama.2019.0692","article-title":"Effect of catheter ablation vs medical therapy on quality of life among patients with atrial fibrillation: the CABANA randomized clinical trial","volume":"321","author":"Mark","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2021.04.092_bib13","doi-asserted-by":"crossref","first-page":"3105","DOI":"10.1016\/j.jacc.2020.04.065","article-title":"Recurrence of atrial fibrillation after catheter ablation or antiarrhythmic drug therapy in the CABANA trial","volume":"75","author":"Poole","year":"2020","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2021.04.092_bib14","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.ahj.2018.02.015","article-title":"Catheter Ablation Versus Antiarrhythmic Drug Therapy for Atrial Fibrillation (CABANA) trial: study rationale and design","volume":"199","author":"Packer","year":"2018","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2021.04.092_bib15","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric estimation from incomplete observations","volume":"53","author":"Kaplan","year":"1958","journal-title":"J\u00a0Am Stat Assoc"},{"key":"10.1016\/j.jacc.2021.04.092_bib16","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","article-title":"Regression models and life-tables (with discussion)","volume":"34","author":"Cox","year":"1972","journal-title":"J\u00a0Royal Statist Soc B"},{"key":"10.1016\/j.jacc.2021.04.092_bib17","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","article-title":"A\u00a0proportional hazards model for the subdistribution of a competing risk","volume":"94","author":"Fine","year":"1999","journal-title":"J\u00a0Am Stat Assoc"},{"key":"10.1016\/j.jacc.2021.04.092_bib18","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1001\/jamacardio.2016.3312","article-title":"Understanding the role of P values and hypothesis tests in clinical research","volume":"1","author":"Mark","year":"2016","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacc.2021.04.092_bib19","doi-asserted-by":"crossref","first-page":"S210","DOI":"10.1054\/S1071-9164(03)00590-6","article-title":"Heart failure in African Americans: pathophysiology and treatment","volume":"9","author":"Yancy","year":"2003","journal-title":"J\u00a0Card Fail"},{"key":"10.1016\/j.jacc.2021.04.092_bib20","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.amjcard.2005.07.002","article-title":"Outcomes by race and etiology of patients with left ventricular systolic dysfunction","volume":"96","author":"Thomas","year":"2005","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2021.04.092_bib21","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1056\/NEJMoa0807265","article-title":"Racial differences in incident heart failure among young adults","volume":"360","author":"Bibbins-Domingo","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2021.04.092_bib22","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12872-019-0998-2","article-title":"Catheter ablation for atrial fibrillation in heart failure with reduced ejection fraction: a systematic review and meta-analysis of randomized controlled trials","volume":"19","author":"AlTurki","year":"2019","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.jacc.2021.04.092_bib23","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.hrthm.2017.12.001","article-title":"Catheter ablation of atrial fibrillation in patients with heart failure and preserved ejection fraction","volume":"15","author":"Black-Maier","year":"2018","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacc.2021.04.092_bib24","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1161\/CIRCULATIONAHA.115.019406","article-title":"Ablation versus amiodarone for treatment of persistent atrial fibrillation in patients with congestive heart failure and an implanted device: results from the AATAC multicenter randomized trial","volume":"133","author":"Di Biase","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2021.04.092_bib25","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1161\/CIRCEP.113.000806","article-title":"A\u00a0randomized controlled trial of catheter ablation versus medical treatment of atrial fibrillation in heart failure (the CAMTAF trial)","volume":"7","author":"Hunter","year":"2014","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.jacc.2021.04.092_bib26","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1016\/j.jacc.2013.01.069","article-title":"A\u00a0randomized trial to assess catheter ablation versus rate control in the management of persistent atrial fibrillation in heart failure","volume":"61","author":"Jones","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2021.04.092_bib27","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1056\/NEJMoa1707855","article-title":"Catheter ablation for atrial fibrillation with heart failure","volume":"378","author":"Marrouche","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2021.04.092_bib28","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1161\/CIRCULATIONAHA.120.050991","article-title":"Ablation versus drug therapy for atrial fibrillation in heart failure: results from the CABANA trial","volume":"143","author":"Packer","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2021.04.092_bib29","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1016\/j.jacc.2017.08.041","article-title":"Catheter ablation versus medical rate control in atrial fibrillation and systolic dysfunction: the CAMERA-MRI study","volume":"70","author":"Prabhu","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2021.04.092_bib30","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.hrthm.2021.01.021","article-title":"Atrial fibrillation burden and heart failure: data from 39,710 individuals with cardiac implanted electronic devices","volume":"18","author":"Steinberg","year":"2021","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacc.2021.04.092_bib31","doi-asserted-by":"crossref","first-page":"76","DOI":"10.7326\/L19-0282","article-title":"Catheter ablation of atrial fibrillation in patients with heart failure","volume":"171","author":"Turagam","year":"2019","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacc.2021.04.092_bib32","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1161\/01.CIR.0000118472.77237.FA","article-title":"Analysis of cause-specific mortality in the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study","volume":"109","author":"Steinberg","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2021.04.092_bib33","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/S0140-6736(96)09145-3","article-title":"European Myocardial Infarct Amiodarone Trial Investigators. Randomised trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT","volume":"349","author":"Julian","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2021.04.092_bib34","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1111\/pace.13165","article-title":"Impact of race and gender on clinical outcomes of catheter ablation in patients with atrial fibrillation","volume":"40","author":"Bukari","year":"2017","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.jacc.2021.04.092_bib35","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1093\/eurheartj\/ehz085","article-title":"Atrial fibrillation ablation in practice: assessing CABANA generalizability","volume":"40","author":"Noseworthy","year":"2019","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2021.04.092_bib36","doi-asserted-by":"crossref","first-page":"e59","DOI":"10.1056\/NEJMp2021971","article-title":"Racial disproportionality in Covid clinical trials","volume":"383","author":"Chastain","year":"2020","journal-title":"N\u00a0Engl J Med"}],"container-title":["Journal of the American College of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109721051111?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109721051111?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T18:14:49Z","timestamp":1777572889000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735109721051111"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["S0735109721051111"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2021.04.092","relation":{},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ablation Versus Drug Therapy for Atrial Fibrillation in Racial and Ethnic Minorities","name":"articletitle","label":"Article Title"},{"value":"Journal of the American College of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2021.04.092","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 by the American College of Cardiology Foundation. Published by Elsevier.","name":"copyright","label":"Copyright"}]}}